From: A stability-indicating HPLC method for estimation of doxylamine succinate in tablets and characterization of its major alkaline stress degradation product
Drug
Concentration* (μg/ml)
Peak area
S. D.
C. V.
DOX
20
758601
± 1510
0.0998
25
1198543
± 4964
0.2624
30
1486948
± 5878
0.2597